Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives
Copyright © 2023 Elsevier B.V. All rights reserved..
Acanthamoeba are known to cause a vision threatening eye infection typically due to contact lens wear, and an infection of the central nervous system. The ability of these amoebae to switch phenotypes, from an active trophozoite to a resistant cyst form is not well understood; the cyst stage is often resistant to chemotherapy, which is of concern given the rise of contact lens use and the ineffective disinfectants available, versus the cyst stage. Herein, for the first time, a range of raloxifene sulfonate/sulfamate derivatives which target nucleotide pyrophosphatase/phosphodiesterase enzymes, were assessed using amoebicidal and excystation tests versus the trophozoite and cyst stage of Acanthamoeba. Moreover, the potential for cytopathogenicity inhibition in amoebae was assessed. Each of the derivatives showed considerable anti-amoebic activity as well as the ability to suppress phenotypic switching (except for compound 1a). Selected raloxifene derivatives reduced Acanthamoeba-mediated host cell damage using lactate dehydrogenase assay. These findings suggest that pyrophosphatase/phosphodiesterase enzymes may be valuable targets against Acanthamoeba infections.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:256 |
---|---|
Enthalten in: |
Molecular and biochemical parasitology - 256(2023) vom: 09. Dez., Seite 111582 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Siddiqui, Ruqaiyyah [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.12.2023 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.molbiopara.2023.111582 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360621333 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM360621333 | ||
003 | DE-627 | ||
005 | 20240313233547.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.molbiopara.2023.111582 |2 doi | |
028 | 5 | 2 | |a pubmed24n1326.xml |
035 | |a (DE-627)NLM360621333 | ||
035 | |a (NLM)37562558 | ||
035 | |a (PII)S0166-6851(23)00040-3 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Siddiqui, Ruqaiyyah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2023 | ||
500 | |a Date Revised 12.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a Acanthamoeba are known to cause a vision threatening eye infection typically due to contact lens wear, and an infection of the central nervous system. The ability of these amoebae to switch phenotypes, from an active trophozoite to a resistant cyst form is not well understood; the cyst stage is often resistant to chemotherapy, which is of concern given the rise of contact lens use and the ineffective disinfectants available, versus the cyst stage. Herein, for the first time, a range of raloxifene sulfonate/sulfamate derivatives which target nucleotide pyrophosphatase/phosphodiesterase enzymes, were assessed using amoebicidal and excystation tests versus the trophozoite and cyst stage of Acanthamoeba. Moreover, the potential for cytopathogenicity inhibition in amoebae was assessed. Each of the derivatives showed considerable anti-amoebic activity as well as the ability to suppress phenotypic switching (except for compound 1a). Selected raloxifene derivatives reduced Acanthamoeba-mediated host cell damage using lactate dehydrogenase assay. These findings suggest that pyrophosphatase/phosphodiesterase enzymes may be valuable targets against Acanthamoeba infections | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Acanthamoeba | |
650 | 4 | |a Anti-amoebic | |
650 | 4 | |a CNS infections | |
650 | 4 | |a Free-living amoebae | |
650 | 4 | |a Raloxifene derivatives | |
650 | 7 | |a sulfamic acid |2 NLM | |
650 | 7 | |a 9NFU33906Q |2 NLM | |
650 | 7 | |a Raloxifene Hydrochloride |2 NLM | |
650 | 7 | |a 4F86W47BR6 |2 NLM | |
650 | 7 | |a Sulfonic Acids |2 NLM | |
650 | 7 | |a Alkanesulfonates |2 NLM | |
650 | 7 | |a Phosphoric Diester Hydrolases |2 NLM | |
650 | 7 | |a EC 3.1.4.- |2 NLM | |
700 | 1 | |a El-Gamal, Mohammed I |e verfasserin |4 aut | |
700 | 1 | |a Sajeev, Sreedevi |e verfasserin |4 aut | |
700 | 1 | |a Zaraei, Seyed-Omar |e verfasserin |4 aut | |
700 | 1 | |a Khan, Naveed Ahmed |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular and biochemical parasitology |d 1981 |g 256(2023) vom: 09. Dez., Seite 111582 |w (DE-627)NLM012594830 |x 1872-9428 |7 nnns |
773 | 1 | 8 | |g volume:256 |g year:2023 |g day:09 |g month:12 |g pages:111582 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.molbiopara.2023.111582 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 256 |j 2023 |b 09 |c 12 |h 111582 |